The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonist-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The enhanced in vitro hematopoietic activity of leridistim, a chimeric dual G-CSF and IL-3 receptor agonist

Published:2002-03 Issue:3 Volume:16 Page:316-326
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Abegg AL,Vickery LE,Bremer ME,Donnelly AM,Doshi PD,Evans ML,Thurman TL,Braford SR,Caparon MH,Bauer SC,Giri JG,Welply JK,McKearn JP,Smith WG

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/2402366.pdf

Reference51 articles.

1. Ganser A, Karthaus M . Clinical use of hematopoietic growth factors Curr Opin Oncol 1996 8: 265–269

2. Ganser A, Karthaus M . Clinical use of hematopoietic growth factors in the myelodysplastic syndromes Leuk Lymphoma 1997 26 (Suppl. 1): 13–27

3. Fraipont V, Sautois B, Baudoux E, Pereira M, Fassotte MF, Hermanne JP, Jerusalem G, Longree L, Schaaf-Lafontaine N, Fillet G, Beguin Y . Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF Transfusion 2000 40: 339–347

4. Thatcher N, Girling DJ, Hopwood P, Sambrook RJ, Qian W, Stephens RJ . Improving survival without reducing quality of life in small-cell lung cancer patients by increasing the dose-intensity of chemotherapy with granulocyte colony-stimulating factor support: results of a British Medical Research Council Multicenter Randomized Trial. Medical Research Council Lung Cancer Working Party J Clin Oncol 2000 18: 395–404

5. Crawford J, Ozer H, Stoller R, Johnson D, Lyman G, Tabbara I, Kris M, Grous J, Picozzi V, Rausch G . Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer N Engl J Med 1991 325: 164–170

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New G-CSF agonists for neutropenia therapy;Expert Opinion on Investigational Drugs;2013-09-27

2. Management of Renal Anemia in Children with Chronic Kidney Disease;Pediatric Dialysis;2011-11-07

3. Production of bioactive human granulocyte-colony stimulating factor in transgenic rice cell suspension cultures;Protein Expression and Purification;2006-05

4. Thrombopoietic Factors in Chronic Bone Marrow Failure States: The Platelet Problem Revisited: Table 1;Clinical Cancer Research;2005-02-15

5. Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention;Leukemia;2003-06-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3